The Stem Cell Network funds regenerative medicine research across Canada from the ground up. SCN’s approach is to catalyze, accelerate, and translate cutting-edge research with the potential to change and save lives. Whether by funding research projects directly, supporting biotech start-ups, collaborating with partners on specialized grants, or enabling conferences and events, SCN funding is powering Canadian regenerative medicine.
SCN is now pleased to announce the second of two national research funding competitions planned for SCN’s 2025-2029 funding cycle. The competition officially launches Monday, August 31, 2026, and will offer 22-month awards. Learn more.
SCN’s national research funding competition supports world-class, translational, regenerative medicine research, across the research continuum, to facilitate health, social and economic benefits for Canadians.
The Round 2 competition officially launches Monday, August 31, 2026, and offers 22-month awards.
Stem Cell Network is deploying a new funding opportunity to directly advance Canadian regenerative medicine biotechnology companies.
SCN and the Rare Diseases: Models & Mechanisms (RDMM) Network are collaborating in support of the RDMM Catalyst Grant program.
On June 16 2025, SCN was pleased to allocate $13.5M to support 36 research projects and clinical trials across the country, with 63 partner organizations committing $19.5M of in kind or cash support.
At SCN we are proud to support researchers and partners across the stem cell and regenerative medicine community on their events, meetings, or conferences.
350 Albert Street,
Suite 325
Ottawa, ON
K1R 1A4
info@stemcellnetwork.ca
Receive the latest news on SCN funding programs and training opportunities, and what’s happening in the stem cell industry, directly in your inbox.
Newsletter sign-up form